MORELLO, LUCIA
MORELLO, LUCIA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse
2022 C. Rusconi, C.Y. Cheah, T.A. Eyre, D. Tucker, P. Klener, E. Gine, L. Crucitti, C. Muzi, S. Iadecola, G. Infante, S. Bernard, R.L. Auer, C. Pagani, M. Duglosz-Danecka, H. Mocikova, T. van Meerten, E. Cencini, A. Marin-Niebla, M.E. Williams, P. Angelillo, P. Nicoli, A. Arcari, L. Morello, D. Mannina, O. Vitagliano, R. Sartori, A. Chiappella, R. Sciarra, P.M. Stefani, M. Dreyling, J.F. Seymour, C. Visco
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
2022 E. Calabretta, A. Guidetti, F. Ricci, M. Di Trani, C. Monfrini, M. Magagnoli, S. Bramanti, D. Maspero, L. Morello, M. Merli, A. Di Rocco, A. Graudenzi, E. Derenzini, M. Antoniotti, D. Rossi, P. Corradini, A. Santoro, C. Carlo-Stella
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse | 2022 | Crucitti L.Infante G.Morello L. + | Article (author) | - | |
| Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics | 2022 | Guidetti, AnnaBramanti, StefaniaMorello, LuciaDerenzini, EnricoCorradini, Paolo + | Article (author) | - |